Drug Injury Watch: New Obesity Drug Qsymia / Qsiva Gets Gets Negative Opinion By European Medicines Agency (EMA)

more+
less-

Drug Injury Watch: New Obesity Drug Qsymia / Qsiva Gets Gets Negative Opinion By European Medicines Agency (EMA)

Combination Pill Of Topamax And Phentremine Was Approved By FDA, But EMA Points To Heart Side Effects, Birth Defects, And Other Safety Issues

http://www.drug-injury.com/druginjurycom/2012/10/qsymia-diet-pill-topamax-topiramate-phentermine-phen-qsiva-ema-fda-safety-issues.html

LOADING PDF: If there are any problems, click here to download the file.

Written by:

more+
less-

Law Offices of Thomas J. Lamb, P.A. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×